Advanced high-grade serous ovarian cancer treated with intensive cytoreductive surgery and chemotherapy: prognostic impact of lymph node involvement: analysis of the French national ESME-Unicancer database
- 25 March 2026
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 52 (6) , 111768
Abstract
No abstract availableKeywords
Funding Information
- Centre Henri Becquerel
- Institut Curie
- Institut Claudius Regaud
This publication has 39 references indexed in Scilit:
- Prognostic role of the peritoneal cancer index in ovarian cancer patients who undergo cytoreductive surgery: a meta-analysisCurrent Problems in Cancer, 2023
- Cancer of the ovary, fallopian tube, and peritoneum: 2021 updateInternational Journal of Gynecology & Obstetrics, 2021
- Cancer statistics for the year 2020: An overviewInternational Journal of Cancer, 2021
- Prognostic value of peritoneal cancer index in primary advanced ovarian cancerEuropean Journal of Surgical Oncology, 2018
- B7-H3-targeted 212Pb radioimmunotherapy of ovarian cancer in preclinical modelsNuclear Medicine and Biology, 2017
- Staging classification for cancer of the ovary, fallopian tube, and peritoneumInternational Journal of Gynecology & Obstetrics, 2013
- Defining the optimal lymphadenectomy cut-off value in epithelial ovarian cancer staging surgery utilizing a mathematical model of validationEuropean Journal of Surgical Oncology, 2013
- Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experienceGynecologic Oncology, 2010
- Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigmGynecologic Oncology, 2009
- Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trialsCancer, 2009